Rapport Therapeutics Inc.
5 clinical trials · Sponsor
◉ Watch Rapport Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures (NCT07594119) | Rapport Therapeutics Inc. | 2026-08-01 |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 (NCT07563881) | Rapport Therapeutics Inc. | 2026-06-05 |
| A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures (NCT07219407) | Rapport Therapeutics Inc. | 2025-12-15 |
| Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder (NCT07046494) | Rapport Therapeutics Inc. | 2025-07-25 |
| Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy (NCT06377930) | Rapport Therapeutics Inc. | 2024-10-10 |
Track Rapport Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.